Literature DB >> 7893282

Age-related and gender-related occurrence of pituitary adenomas.

T Mindermann1, C B Wilson.   

Abstract

OBJECTIVE: To evaluate the various types of pituitary adenomas according to sex and age group. Few studies have attempted such an analysis, and most have focused on specific age groups, especially children. Recent data suggest that the frequency of different types of pituitary adenomas varies according to age and sex.
DESIGN: A retrospective review of the records of 2230 patients who underwent surgery for a pituitary adenoma at the University of California, San Francisco (UCSF), between January 1969 and June 1993.
METHODS: The distribution of tumours was analysed according to age at surgery, sex, and the clinical phenotype of the tumour. Age groups were defined as the decades of life.
RESULTS: Prolactinomas were the most common tumours (39%), followed by endocrine-inactive adenomas, growth-hormone-releasing adenomas, and adrenocorticotrophic hormone-releasing adenomas causing Cushing's disease; ACTH-releasing adenomas causing Nelson's syndrome and thyrotrophin (TSH)-releasing adenomas were rare. The female-to-male ratio differed considerably between the various adenoma types and between age groups. Prolactinomas, ACTH-releasing adenomas, and TSH-releasing adenomas occurred mostly in females; endocrine-inactive and GH-releasing adenomas occurred mostly in males. In older age groups, all adenoma types, except for endocrine-inactive adenomas, tended to assume a more balanced gender distribution. Among patients with prolactinomas, endocrine-inactive, ACTH-releasing, and to a lesser extent GH-releasing adenomas, the greatest discrepancy in gender distribution seemed to coincide with the peak occurrence of each tumour type. The peak occurrence was from the second to the fifth decade of life for prolactinomas and from the fourth to the eighth decade for endocrine-inactive adenomas. GH-releasing, ACTH-releasing, and TSH-releasing adenomas were more evenly distributed throughout the adult life span.
CONCLUSIONS: The frequency of pituitary adenomas varies greatly according to age and sex. The various adenoma types have their peak occurrence in distinctly different age groups and differ greatly in their female-to-male ratios. The female-to-male ratio for a given adenoma type varies greatly with age.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7893282     DOI: 10.1111/j.1365-2265.1994.tb02557.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  50 in total

1.  Gamma knife stereotactic radiosurgery for drug resistant or intolerant invasive prolactinomas.

Authors:  Xiaomin Liu; Hideyuki Kano; Douglas Kondziolka; Kyung-Jae Park; Aditya Iyer; Samuel Shin; Ajay Niranjan; John C Flickinger; L Dade Lunsford
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

Review 2.  Medical treatment of prolactinomas.

Authors:  Annamaria Colao; Silvia Savastano
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

3.  Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.

Authors:  Arijit Chattopadhyay; Anil Bhansali; Shariq R Masoodi
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  The epidemiology of prolactinomas.

Authors:  Antonio Ciccarelli; Adrian F Daly; Albert Beckers
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

5.  Investigation of a cluster of pituitary adenomas in workers in the aluminum industry.

Authors:  M R Cullen; H Checkoway; B H Alexander
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

Review 6.  Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review.

Authors:  Tomáš Česák; Pavel Poczos; Jaroslav Adamkov; Jiří Náhlovský; Petra Kašparová; Filip Gabalec; Petr Čelakovský; Ondrej Choutka
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

7.  Variations in referral patterns for hypophysectomies among pediatric patients with sellar and parasellar tumors.

Authors:  Debraj Mukherjee; Hasan A Zaidi; Thomas A Kosztowski; Aditya Halthore; George I Jallo; Roberto Salvatori; David C Chang; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

8.  Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.

Authors:  Bernhard Schaller
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 9.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  Clinical significance of Ki-67 labeling index in pituitary macroadenoma.

Authors:  Kyung-Il Paek; Seon-Hwan Kim; Shi-Hun Song; Seung-Won Choi; Hyeon-Song Koh; Jin-Young Youm; Youn Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.